PRIMECAP Odyssey Growth Fund POGRX seeks capital appreciation. POGRX normally invests in common stocks of U.S. companies that possess high earnings growth. POGRX may invest in companies from different sectors and diverse market-cap.
This Large Cap Growth producthas a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 13.8% and 5 year almost 18.7%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
POGRX’s performance, as of the last filing, when compared to funds in its category was in the top 5% over the past 1 year, and in the top 3% over the past 3 years and in the top 1% over the past 5 years.
The PRIMECAP Odyssey Growth Fund, as of the last filing, allocates their fund in top two major groups; Large Growth and Large Value. Further, as of the last filing, Abiomed Inc, Seattle Genetics Inc and Eli Lilly and Co were the top holdings for POGRX.
This Zacks Rank #2 (Buy) was incepted in November 2004 and is managed by Primecap Oddys. POGRX carries an expense ratio of 0.66% and requires a minimal initial investment of $2,000.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
View All Zacks #1 Ranked Mutual Funds
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Get Your Free (POGRX): Fund Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research